Herbas VPB

Print
EN | LT
LT - APOMORPHINE FOR THE TREATMENT OF METHYLPHENIDATE INDUCED HYPERACTIVITY
EN - APOMORPHINE FOR THE TREATMENT OF METHYLPHENIDATE INDUCED HYPERACTIVITY

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/473 (2006.01)
A61K 31/485 (2013.01)
A61K 31/13 (2006.01)
C07D 221/18 (2013.01)
C07D 401/06 (2013.01)
A61K 31/485 (2006.01)
C07D 409/06 (2013.01)
C07D 221/02 (2006.01)
C07D 489/00 (2006.01)
C07D 489/02 (2013.01)
A61K 9/00 (2006.01)
C07D 211/34 (2013.01)
A61K 45/06 (2006.01)
A61K 45/06 (2013.01)
A61K 9/50 (2006.01)
A61K 31/137 (2013.01)
A61K 31/165 (2013.01)
A61P 25/00 (2006.01)
A61K 31/445 (2013.01)
A61K 9/48 (2006.01)
A61K 31/4458 (2013.01)
A61K 9/16 (2006.01)
A61K 31/4468 (2013.01)
A61K 9/28 (2006.01)
A61K 31/137 (2006.01)
A61K 31/4535 (2013.01)
A61K 31/165 (2006.01)
A61K 31/454 (2013.01)
A61K 31/445 (2006.01)
A61K 31/473 (2013.01)
A61K 31/4458 (2006.01)
A61K 36/74 (2013.01)
A61K 31/4468 (2006.01)
A61K 9/2886 (2013.01)
A61K 31/4535 (2006.01)
A61K 9/5078 (2013.01)
A61K 31/454 (2006.01)
A61K 9/5084 (2013.01)
A61K 36/74 (2006.01)
A61K 9/1676 (2013.01)
A61P 25/00 (2018.01)
European patent
(11) Number of the document 3294278
(13) Kind of document T
(96) European patent application number 16792259.0
Date of filing the European patent application 2016-05-11
(97) Date of publication of the European application 2018-03-21
(45) Date of publication and mention of the grant of the patent 2022-05-11
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/IB2016/000688
Date 2016-05-11
PCT application publication
(87) Number WO 2016/181218
Date 2016-11-17
Priority applications
(30) Number Date Country code
201562160627 P 2015-05-13 US
Inventors
(72)
SELA, Yoram , IL
LAMENSDORF, Itschak , IL
Grantee
(73) 4P-Pharma , Campus de l'Institut Pasteur de Lille 1, rue du Professeur Calmette, 59000 Lille, FR
Title
(54) APOMORPHINE FOR THE TREATMENT OF METHYLPHENIDATE INDUCED HYPERACTIVITY
  APOMORPHINE FOR THE TREATMENT OF METHYLPHENIDATE INDUCED HYPERACTIVITY